Rapid Therapeutic Science Labs Inc (RTSL)

[dieseld28]

Anyone know why the drop from .04 3 weeks ago?

[dieseld28]

Anyone know why the drop from .04 3 weeks ago?

[i_like_bb_stock]

see what happens today

[stockrider]

Not really, looks like profit takers. With this low float it can happen, but also goes up same way. If volume keeps coming this can go wild on the upside to pennies quickly

[i_like_bb_stock]

doubt it looks note conversion ugh

[Natural Trader]

not holding up here

[Natural Trader]

is that .009 fake wall?

[stockrider]

Would be happy if this goes to 0.50+. With this OS market cap will be still tiny at 4.5M, very doable I think if volume keeps coming

[stockrider]

With only 2.3M in float this is going to wild soon. Watch the explosion when shorts get squeezed on this one with this tiny float

[i_like_bb_stock]

Yea there’s Ascm making sure it stops fuckers

[abazaba375]

Break .02 and it’s on

[i_like_bb_stock]

yes man this could really pop

[$b_rich$]

Nice one!

[i_like_bb_stock]

2.3M float grabbed some tiny dilution but this is insane possible runner even on the otc

[Renee]

RTSL one for 25 reverse split. **PPS closed at .27

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[MegaDeath]

Rapid Therapeutic Finalizes Lab Work on Pharmaceutical Formulas

DALLAS, June 10, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today that it has concluded lab development on three (3) formulas related to manufacturing of pharmaceutical grade isolates used in both metered dose inhalers and other aerosol products.

RTSL has developed three (3) proprietary pharmaceutical formulas, two (2) for cannabidiol (CBD) and one (1) for cannabigerol (CBG), to initially be used in Metered Dose Inhalers (MDI). One CBD formula is expected to be used in testing of the MDI which the Company plans to submit to the U.S. Food and Drug Administration (FDA) in connection with an Investigational New Drug Application (IND), as previously announced. The other two are planned to be used in RTSL’s other products.

RTSL’s CEO, Donal R. Schmidt, Jr. stated, “We initially set out to find an ultra-pure, unadulterated pharmaceutical grade CBD isolate to use in our MDI. Early on we learned the purity level of an isolate is materially related to airway irritation and the level of cough reflex when using an MDI. We also learned CBD isolate is not chemically compatible with metered dose inhalers without significant modifications in the manufacturing process. In short, we were unsatisfied with any product we could source in the hemp space to meet our needs. As such, we set out to engineer a quality isolate to meet our needs.”

“With the purchase of Razor Jacket and the addition of Dr. Drinkwine, each as previously announced, we learned how to manufacture pharmaceutical grade isolate in-house. We believe our process is unique and will result in one or more patents being granted to RTSL. Once the patent applications have been filed, which are planned to be filed in the next few weeks, we expect to release the details of our findings, which we believe will make a significant impact in the hemp space related to isolate manufacturing.”

In conclusion, Mr. Schmidt stated, “At this point, as we head to market with other non-MDI products and while we are preparing to submit the IND, we believe we are well positioned as we have an ISO 6 certified aerosol filling lab, we are progressing well on our way to completion of our Good Manufacturing Process (GMP) certification, and we believe we have true pharmaceutical grade Active Pharmaceutical Ingredients (API).”

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1919246

[MegaDeath]

Rapid Therapeutic Prepares to bring Sublingual Spray Products to Market

DALLAS, June 08, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today it is preparing to launch a marketing and sales campaign of its recently enhanced sublingual spray line (which is applied via a spray into the mouth).

These sublingual sprays are made using RTSL’s proprietary pharmaceutical grade isolates in blends for multiple flavors and terpenes. In addition, the sprays are manufactured on the same exact equipment as RTSL’s metered dose inhalers (MDI), in the company’s existing ISO Level 6 laboratory, following Good Manufacturing Practice (GMP) standards.

RTSL’s CEO, Donal R. Schmidt, Jr. stated, “Our decision to file an IND application for our flagship MDI containing Cannabidiol (CBD), as previously announced, requires we remove this MDI product from the market while the application is pending. Nevertheless, this removal will not affect our use of pure pharmaceutical isolates formulas we have developed or our existing aerosol equipment. In fact, in addition to the sublingual sprays we are preparing to market, we are also testing nasal sprays and topical sprays, using our existing equipment and formulas for planned delivery in the fourth quarter.”

These products are expected to be sold both as branded products and on a white label basis in RTSL’s existing sales channels.

Mr. Schmidt continued, “Based upon discussions with our existing customers, as well as new contacts, we expect significant demand for these products. Although the bioavailability of a sublingual spray is generally not as high as an MDI, it nonetheless typically has higher bioavailability than oral pills and topicals. Regardless, when we discussed the availability of the sublingual spray products with our customers, almost all of them recognize that our specifically manufactured pharmaceutical grade isolates set us apart from other hemp product producers. In short, we have a non-toxic, pure isolate product that deliverers the exact dose each and every use.”

In conclusion, Mr. Schmidt observed that, “RTSL is branding itself as a biopharmaceutical outlier in the hemp space. We make pure products with pharmaceutical grade components on well proven aerosol equipment that delivers safe non-toxic products at known consistent dosage.”

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1916875

[MegaDeath]

Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs

DALLAS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on employing Metered Dose Inhaler (MDI) technology to deliver non-psychoactive cannabinoid compounds, announced today that it has hired Dr. Duane Drinkwine, Ph.D., to oversee all laboratory operations for the Company.

Dr. Drinkwine comes to RTSL with 30+ years of experience in the pharmaceutical industry. He has significant experience in isolate crystallization. For the last 5 years he worked as a consulting engineer for multiple laboratory equipment manufacturers in both “Big Pharma” and the hemp industry. For 10+years he worked for GlaxoSmithKline as a Laboratory Reactor Scientist in the process safety group and scale up chemistry.

RTSL’s CEO, Donal R. Schmidt, Jr. states, “Dr. Drinkwine was instrumental in development of our proprietary intellectual property wherein a pharmaceutical grade cannabinoid isolate was perfected. Dr. Drinkwine was the person who built Razor Jacket, LLC’s lab and processes, and the deciding reason we purchased such assets. We believe that his knowledge about isolate production of prescription Active Pharmaceutical Ingredients (API) in the pharmaceutical industry world gives us an advantage in several areas, least of all, safety, and ultimately Food and Drug Administration (FDA) interaction.

He is reviewing all our formulations for safety and purity. It is critical that our MDI not cause any adverse events such as a laryngospasm or bronchospasm. In addition to formulations, he will be responsible for oversight related to Current Good Manufacturing Practice (cGMP), and Occupational Safety and Health Administration (OSHA) and United States Environmental Protection Agency (EPA) regulations.

It is axiomatic that RTSL needed a scientist of Dr. Drinkwine’s caliber as we make new inroads into the use of cannabinoids by worldwide consumers.”

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1792978

[MegaDeath]

Rapid Therapeutic Selects Clinical Research Center to Start Clinical Trials Using its Proprietary CBD and CBG Formulation

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1757435

[MegaDeath]

Rapid Therapeutic Completes $14 Million Acquisition of Razor Jacket

Razor Jacket is an Isolate Lab capable of producing up to 250 kilograms per month of 99.9% pure medical grade isolate

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1754862

[TTider]

Very exciting news, man they are really looking to be the big name in CBD, I love how it’s drops production cost for each MDI down by 50%. They mentioned looking for a buyout, I wouldn’t be a bit surprised if this LOI starts peaking potential buyers interest

[whytestocks]

JUST IN: $RTSL Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually

DALLAS, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, s...

Got this from RTSL - Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually

[MegaDeath]

Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually

LOI to acquire Isolate Lab which will increase internal production of up to 150 kilograms per month of 99.9% pure isolate

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1703131

[whytestocks]

News: $RTSL Cannabidiol Sales Are Predicted To Mushroom Rapidly While Newest CBD, CBG, CBD Products Hit the Market

August 18, 2020 Palm Beach, FL – August 18, 2020 – The legalized cannabis market is rapidly growing as one country after another acknowledges and approves its use for medicinal and wellness purposes. In numerous countries, starting with the U.S. and Canada, cannabis ...

In case you are interested RTSL - Cannabidiol Sales Are Predicted To Mushroom Rapidly While Newest CBD, CBG, CBD Products Hit the Market

[whytestocks]

News: $RTSL Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory

DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, su...

Got this from RTSL - Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory

[MegaDeath]

Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1672787

[TTider]

Yes it’s been a pretty nice steady rise, not much profit taking at these levels which means ppl think it has more to give RTSL $$$

[resx18]

Great Day $RTSL

[TTider]

Great week for all shareholders, nice steady increase in SP as well as great communication from the company with clear signs things are going in the right direction

[TTider]

Another very nice day, RTSL keeps trending up. Looking forward to launch of new product later this month, plus the ramp up in advertising mentioned today, more eyes on RTSL

[TTider]

It seems this company plan is coming together very nicely, plus August 17th a new product line being launched

[MegaDeath]

Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhaler”

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1663694

https://nhaler.com/

https://www.rxoid.com/

https://rtslco.com/

[whytestocks]

News: $RTSL Billion Dollar Cannabidiol Infused Products Market Growing Usage Continues to Skyrocket

August 4, 2020 Palm Beach, FL – August 4, 2020 – The cannabis infused products market is expected to gain market growth in the forecast period of 2020 to 2027. A recent report from industry insider Date Bridge market Research also says that the CBD Oil Extract Market...

Find out more RTSL - Billion Dollar Cannabidiol Infused Products Market Growing Usage Continues to Skyrocket

[whytestocks]

News: $RTSL Rapid Therapeutic Science Files with FDA to Register Facility and Products

DALLAS, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver aerosolized cannabinoids, such as...

Got this from RTSL - Rapid Therapeutic Science Files with FDA to Register Facility and Products

[TTider]

Looks like things are falling into place nicely, the MDI product is the best method for administration I think that is what differentiates this CBD company from the rest in this crowded sector. Excited to see what end of year has in store in terms of potential new contracts etc...

[MegaDeath]

Rapid Therapeutic Science Files with FDA to Register Facility and Products

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1660526

[TTider]

Nice rebound to end the day. Hoping we start trending back up from this area.

[TTider]

Flippers look to be about done selling from the recent pps spike. We should start to see a trend up starting mid next week I assume unless news of more contracts are PRd. This could be the prime loading zone, get in cheap while u still can!

[TTider]

They seem to progressing pretty nicely. Orders are beginning to increase will be interesting to see how this team plans to move forward to capture more of the CBD market in the upcoming months.

[MegaDeath]

Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1643841

[resx18]

Gap up $RTSL

[resx18]

Great Company RTSL

[whytestocks]

News: $RTSL CBD Infused Products Popularity Rising Fast In Over-The-Counter Retail Stores

July 9, 2020 Palm Beach, FL – July 9, 2020 – As medical and recreational legalization of cannabis continues to make cannabis products more mainstream, more consumers are shifting their views on the plant, and retailers are taking notice. Cannabis — and, in par...

In case you are interested RTSL - CBD Infused Products Popularity Rising Fast In Over-The-Counter Retail Stores

[whytestocks]

News: $RTSL Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers

DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of cannabinoids in the legal hemp and cannabis space using Metered Dose Inhalers (MDIs), announced today t...

In case you are interested RTSL - Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers

[MegaDeath]

Highest volume in 52 weeks!

[MegaDeath]

Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1641030

[whytestocks]

Article: $RTSL Rapid Therapeutic (OTC: RTSL) Breaking News Update

Rapid Therapeutic (OTC: RTSL) Recent News Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) announced today that it has delivered an initial...

Read the whole news RTSL - Rapid Therapeutic (OTC: RTSL) Breaking News Update

[resx18]

DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol delivery systems based on pressurized Metered Dose Inhaler (MDI) technology, announced today that it has delivered an initial 2,000 units under its previously announced 100,000 unit order.

Rapid Therapeutic Science Laboratories, Inc. Chairman and CEO, Donal R. Schmidt, Jr. stated, “RTSL is moving forward on its first major wholesale contract. We have completed the first shipment totaling 2,000 units of our proprietary CBD/CBG formula under our white label order of 100,000 units we previously announced. These MDIs are currently being sold through doctors’ offices and in pharmacies across the United States. The initial lot of 2,000 was presold by our customer before we manufactured them. We will continue to manufacture and ship under this order as we discuss additional white label opportunities with other distributors. This first shipment demonstrates our ability to deliver large unit orders on a timely basis while preserving product quality.”

[MegaDeath]

Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1639993

[MegaDeath]

Rapid Therapeutic Enters Contract for Certified Lab for Manufacturing Consistent with FDA Rules

https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1634842